Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melanoma (Skin Cancer)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04521686
What this trial is testing

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Who this might be right for
CholangiocarcinomaChondrosarcomaGlioma+1 more
Eli Lilly and Company 200
Early research (Phase 1)Study completedNCT00527761
What this trial is testing

Taxotere/Temodar/Cisplatin Study in Melanoma Patients

Who this might be right for
Metastatic Melanoma
M.D. Anderson Cancer Center 23
Early research (Phase 1)Study completedNCT01656642
What this trial is testing

A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Genentech, Inc. 67
Early research (Phase 1)Active Not RecruitingNCT05176470
What this trial is testing

Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients

Who this might be right for
Locally Advanced MelanomaPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8+2 more
Richard Wu 2
Early research (Phase 1)Ended earlyNCT05576077
What this trial is testing

TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerUveal Melanoma+3 more
Turnstone Biologics, Corp. 31
Early research (Phase 1)Study completedNCT01752257
What this trial is testing

EF5 in Melanoma Patients

Who this might be right for
Melanoma
Douglas Tyler 15
Testing effectiveness (Phase 2)Study completedNCT00466687
What this trial is testing

Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma
Vanderbilt-Ingram Cancer Center 34
Large-scale testing (Phase 3)Looking for participantsNCT06624644
What this trial is testing

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more
Linnaeus Therapeutics, Inc. 135
Testing effectiveness (Phase 2)Study completedNCT00001832
What this trial is testing

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 170
Not applicableUnknownNCT00450593
What this trial is testing

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

Who this might be right for
Hereditary Multiple MelanomaMelanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 5,000
Not applicableEnded earlyNCT02339987
What this trial is testing

Procure Tumor and Initiate Melanoma Tumor-Reactive Tumor Infiltration

Who this might be right for
Melanoma
Saint John's Cancer Institute 27
Not applicableWithdrawnNCT02309632
What this trial is testing

Pancreatic Cancer Screening of High-Risk Individuals in Arkansas

Who this might be right for
Pancreatic NeoplasmsPeutz-Jegher's SyndromeBRCA1 Gene Mutation+5 more
University of Arkansas
Testing effectiveness (Phase 2)Looking for participantsNCT06630611
What this trial is testing

Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Who this might be right for
MelanomaNon Small Cell Lung CancerCervical Cancer
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)Study completedNCT05864144
What this trial is testing

SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorHead and Neck Cancer+19 more
Sensei Biotherapeutics, Inc. 98
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Early research (Phase 1)Study completedNCT00844064
What this trial is testing

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Who this might be right for
Pancreatic NeoplasmsMelanomaColorectal Neoplasms
Isarna Therapeutics GmbH 62
Testing effectiveness (Phase 2)WithdrawnNCT01689870
What this trial is testing

Study of the Combination of Anti-OX40 and Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Ludwig Institute for Cancer Research
Not applicableEnded earlyNCT04577729
What this trial is testing

The IRMI-FMT Trial

Who this might be right for
Fecal Microbiota TransplantationMalignant Melanoma Stage IIIMalignant Melanoma Stage IV
Medical University of Graz 5
Not applicableLooking for participantsNCT04354064
What this trial is testing

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Who this might be right for
Healthy VolunteerProstate CancerHead and Neck Cancer+10 more
Washington University School of Medicine 100
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Next Page